BRO Q1 2026 Earnings EPS Beats Estimates Stock Slips Despite Positive Surprise Seneca Foods Q1 2026 Earnings Strong Profitability Amid Market Headwinds CanFite Biopharma Q4 2023 Earnings Significant EPS Surprise as Biotech Focuses on Clinical Pipeline AARD Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline Progress YDKG Q4 2012 Earnings EPS Misses Estimates Amid Challenging Quarter Marchex MCHX Q1 2026 Earnings EPS Falls Short of Consensus in Challenging Quarter